NO20084701L - Ny heterocyklisk forbindelse eller salt eller intermediat derav - Google Patents

Ny heterocyklisk forbindelse eller salt eller intermediat derav

Info

Publication number
NO20084701L
NO20084701L NO20084701A NO20084701A NO20084701L NO 20084701 L NO20084701 L NO 20084701L NO 20084701 A NO20084701 A NO 20084701A NO 20084701 A NO20084701 A NO 20084701A NO 20084701 L NO20084701 L NO 20084701L
Authority
NO
Norway
Prior art keywords
salt
substituted
group
heterocyclic compound
new heterocyclic
Prior art date
Application number
NO20084701A
Other languages
English (en)
Norwegian (no)
Inventor
Taro Kiyoto
Junichi Ando
Tadashi Tanaka
Yasuhiro Tsutsui
Mai Yokotani
Toshiya Noguchi
Fumihito Ushiyama
Hiroki Urabe
Hiromasa Horikiri
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO20084701L publication Critical patent/NO20084701L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20084701A 2006-05-26 2008-11-10 Ny heterocyklisk forbindelse eller salt eller intermediat derav NO20084701L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006146588 2006-05-26
PCT/JP2007/060606 WO2007138974A1 (fr) 2006-05-26 2007-05-24 Nouveau composé hétérocyclique et sel et intermédiaire correspondants

Publications (1)

Publication Number Publication Date
NO20084701L true NO20084701L (no) 2009-02-06

Family

ID=38778494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084701A NO20084701L (no) 2006-05-26 2008-11-10 Ny heterocyklisk forbindelse eller salt eller intermediat derav

Country Status (18)

Country Link
US (2) US8211908B2 (fr)
EP (1) EP2022793B1 (fr)
JP (1) JP5171618B2 (fr)
KR (1) KR101409261B1 (fr)
CN (1) CN101454319B (fr)
AU (1) AU2007268749B2 (fr)
BR (1) BRPI0712163A2 (fr)
CA (1) CA2652501C (fr)
ES (1) ES2476423T3 (fr)
HK (1) HK1133874A1 (fr)
IL (1) IL195346A (fr)
MX (1) MX2008014908A (fr)
NO (1) NO20084701L (fr)
NZ (1) NZ573032A (fr)
RU (1) RU2434868C2 (fr)
SG (1) SG164384A1 (fr)
WO (1) WO2007138974A1 (fr)
ZA (1) ZA200809782B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (fr) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. Nouveau composé hétérocyclique azoté et sel de celui-ci
PL1954697T3 (pl) * 2005-10-21 2010-07-30 Glaxo Group Ltd Peri skondensowane tricykliczne związki użyteczne jako środki przeciwbakteryjne
CN101454319B (zh) 2006-05-26 2012-06-27 富山化学工业株式会社 新杂环化合物或其盐及其中间体
EP1992628A1 (fr) 2007-05-18 2008-11-19 Glaxo Group Limited Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones
JP5315239B2 (ja) * 2006-07-20 2013-10-16 グラクソ グループ リミテッド Ｎ−エチルキノロンおよびｎ−エチルアザキノロンの誘導体およびアナログ
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
WO2008071964A1 (fr) * 2006-12-15 2008-06-19 Astrazeneca Ab Bactéricides à base de naphthyridine
WO2008071962A1 (fr) * 2006-12-15 2008-06-19 Astrazeneca Ab Ptéridines et pyrimidinopyridines utilisées en tant qu'agents antibactériens
EP2221309B1 (fr) * 2007-11-26 2013-07-24 Toyama Chemical Co., Ltd. Dérivé de naphtyridine monohydratée et son procédé de fabrication
JP5620636B2 (ja) * 2007-11-26 2014-11-05 富山化学工業株式会社 新規な複素環化合物またはその塩を含有する抗菌剤
EP2080761A1 (fr) * 2008-01-18 2009-07-22 Glaxo Group Limited Composés
AR070458A1 (es) 2008-02-22 2010-04-07 Actelion Pharmaceuticals Ltd Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
AU2009254738B2 (en) * 2008-06-03 2014-05-08 Idorsia Pharmaceuticals Ltd [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
JPWO2010027002A1 (ja) * 2008-09-05 2012-02-02 塩野義製薬株式会社 Ｐｉ３ｋ阻害活性を有する縮環モルホリン誘導体
TWI436999B (zh) * 2008-10-10 2014-05-11 Actelion Pharmaceuticals Ltd 唑啶基抗生素
TW201022279A (en) * 2008-11-14 2010-06-16 Astrazeneca Ab Chemical compounds
KR101322496B1 (ko) 2008-11-17 2013-10-29 에프. 호프만-라 로슈 아게 나프틸아세트산
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
WO2010088697A2 (fr) * 2009-02-02 2010-08-05 Medtronic, Inc. Accessoire antimicrobien pour dispositif médical implantable
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
TW201209056A (en) * 2010-05-25 2012-03-01 Taisho Pharmaceutical Co Ltd Novel heterocyclic compound or salt thereof
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
JPWO2012108376A1 (ja) 2011-02-07 2014-07-03 第一三共株式会社 アミノ基含有ピロリジノン誘導体
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
EP2785721A1 (fr) 2011-11-30 2014-10-08 Actelion Pharmaceuticals Ltd. Antibiotiques d'octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one 3,7-disubstituée
EP3733184B1 (fr) * 2013-03-14 2023-08-30 Icahn School of Medicine at Mount Sinai Composés de pyrimidine pour l'utililisation dans la traitment de cancer
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2019113419A1 (fr) * 2017-12-08 2019-06-13 The Rockefeller University Ligands du récepteur opioïde kappa pyrano [3,4-b] pyrazine pour le traitement de l'accoutumance, du prurit, de la douleur et de l'inflammation
US20210052597A1 (en) * 2018-01-29 2021-02-25 Cadila Healthcare Limited Heterocyclic compounds useful as antibacterial agents
CN109678793B (zh) * 2019-01-12 2020-08-04 上海卡洛化学有限公司 一种5-氟-3-氨基吡啶的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4103257A (en) 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azaquinolone dye lasers
US5801183A (en) 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
JP4370002B2 (ja) * 1997-08-08 2009-11-25 富山化学工業株式会社 キノロンカルボン酸誘導体またはその塩
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
WO2002066482A1 (fr) 2001-01-17 2002-08-29 Purdue Research Foundation Procede et composes associes pour former des nanotubes
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
WO2004054974A2 (fr) * 2002-12-13 2004-07-01 Smithkline Beecham Corporation Antagonistes de ccr5 utiles comme agents therapeutiques
EP1720856B1 (fr) * 2004-02-11 2013-08-14 GlaxoSmithKline LLC Inhibiteurs de l'integrase du vih
US20070254872A1 (en) 2004-07-08 2007-11-01 Glaxo Group Limited Antibacterial Agents
JP2008507543A (ja) * 2004-07-22 2008-03-13 グラクソ　グループ　リミテッド 抗細菌剤
DE602005024151D1 (de) * 2004-08-02 2010-11-25 Glaxo Group Ltd Antibakterielle mittel
JP5314244B2 (ja) * 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
US20090131444A1 (en) * 2005-05-24 2009-05-21 Astrazeneca Ab Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (fr) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. Nouveau composé hétérocyclique azoté et sel de celui-ci
CN101454319B (zh) 2006-05-26 2012-06-27 富山化学工业株式会社 新杂环化合物或其盐及其中间体
EP1992628A1 (fr) 2007-05-18 2008-11-19 Glaxo Group Limited Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones
WO2008071964A1 (fr) 2006-12-15 2008-06-19 Astrazeneca Ab Bactéricides à base de naphthyridine
WO2008071962A1 (fr) 2006-12-15 2008-06-19 Astrazeneca Ab Ptéridines et pyrimidinopyridines utilisées en tant qu'agents antibactériens
WO2009001126A1 (fr) 2007-06-27 2008-12-31 Astrazeneca Ab Dérivés de pipéridine substitués et leur utilisation comme agents antibactériens
EP2221309B1 (fr) 2007-11-26 2013-07-24 Toyama Chemical Co., Ltd. Dérivé de naphtyridine monohydratée et son procédé de fabrication

Also Published As

Publication number Publication date
AU2007268749B2 (en) 2012-07-26
SG164384A1 (en) 2010-09-29
NZ573032A (en) 2010-12-24
ZA200809782B (en) 2010-02-24
JP5171618B2 (ja) 2013-03-27
CN101454319A (zh) 2009-06-10
CA2652501A1 (fr) 2007-12-06
CA2652501C (fr) 2014-07-08
EP2022793A4 (fr) 2010-09-08
US20120226035A1 (en) 2012-09-06
RU2434868C2 (ru) 2011-11-27
EP2022793A1 (fr) 2009-02-11
KR101409261B1 (ko) 2014-06-18
US8211908B2 (en) 2012-07-03
HK1133874A1 (en) 2010-04-09
WO2007138974A1 (fr) 2007-12-06
IL195346A0 (en) 2009-08-03
RU2008151754A (ru) 2010-07-10
AU2007268749A1 (en) 2007-12-06
JPWO2007138974A1 (ja) 2009-10-08
KR20090018976A (ko) 2009-02-24
IL195346A (en) 2013-02-28
EP2022793B1 (fr) 2014-06-04
US8367831B2 (en) 2013-02-05
US20090198063A1 (en) 2009-08-06
ES2476423T3 (es) 2014-07-14
CN101454319B (zh) 2012-06-27
MX2008014908A (es) 2009-05-13
BRPI0712163A2 (pt) 2012-03-13

Similar Documents

Publication Publication Date Title
NO20084701L (no) Ny heterocyklisk forbindelse eller salt eller intermediat derav
WO2007016392A3 (fr) Composes de benzothiazole et d'azabenzothiazole utiles en tant qu'inhibiteurs de kinase
WO2008108380A3 (fr) Composés de pyrrole
WO2009016841A1 (fr) Dérivé d'oxopyrazine et herbicide
CY1111671T1 (el) Ετεροκυκλικη ενωση
EA201170632A1 (ru) Цефалоспорины, содержащие катехольную группу
WO2012080284A3 (fr) Composés hétérocycliques azotés 6,6-condensés substitués et leurs utilisations
EA200970171A1 (ru) Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20064418L (no) Nye amido-substituerte hydroksy-6-fenylfenantridiner
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
TW200633991A (en) Chemical compounds
NO20065178L (no) Tienopyridinderivater
MY153720A (en) Oxazole compound and pharmaceutical composition
TW200745028A (en) Novel sulphonylpyrroles
MY141255A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
GB0521508D0 (en) Organic compounds
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
ATE338461T1 (de) Pyrazolpyrimidinfungizide
TW200740752A (en) 4-Biarylyl-1-phenylazetidin-2-ones
TW200745027A (en) Novel sulphonylpyrroles
UA105185C2 (uk) Піроли
WO2009057811A3 (fr) Composé hétérocyclique et composition pharmaceutique contenant ledit composé
IN2012DN00758A (fr)
BRPI0619894B8 (pt) composto de amina e composição farmacêutica
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav